{"id":4418,"date":"2019-03-26T05:37:16","date_gmt":"2019-03-26T05:37:16","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4418"},"modified":"2019-03-26T05:37:16","modified_gmt":"2019-03-26T05:37:16","slug":"%e5%8d%95%e8%8d%af%e7%a7%91%e6%af%94%e7%be%8e%e6%9b%bf%e5%b0%bc%e6%b2%bb%e7%96%97%e6%88%90%e4%ba%ba%e5%85%a8%e8%ba%ab%e6%80%a7%e7%bb%84%e7%bb%87%e7%bb%86%e8%83%9e%e5%a2%9e%e7%94%9f%e7%97%87%e7%9a%84ii","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/zh\/study_trials\/phase-2-trial-of-single-agent-cobimetinib-for-adults-with-systemic-histiocytosis\/","title":{"rendered":"\u5355\u836f\u79d1\u6bd4\u7f8e\u66ff\u5c3c\u6cbb\u7597\u6210\u4eba\u5168\u8eab\u6027\u7ec4\u7ec7\u7ec6\u80de\u589e\u751f\u75c7\u7684II\u671f\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p><strong>\u7814\u7a76\u76ee\u7684\uff1a<\/strong> \u8fd9\u662f\u4e00\u9879\u9488\u5bf9\u57c3\u5c14\u5fb7\u6d77\u59c6-\u5207\u65af\u7279\u75c5\uff08ECD\uff09\u60a3\u8005\u7684\u65b0\u836f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u9002\u7528\u4e8e\uff1a(1) ECD\u7ec4\u7ec7\u4e2d\u672a\u68c0\u6d4b\u5230BRAF\u7a81\u53d8\uff0c\u6216(2) \u7ec4\u7ec7\u4e2d\u68c0\u6d4b\u5230BRAF\u7a81\u53d8\uff0c \u4f46\u65e0\u6cd5\u83b7\u5f97BRAF\u6291\u5236\u5242\uff0c\u6216\u8005\u66fe\u670d\u7528\u8fc7BRAF\u6291\u5236\u5242\u4f46\u65e0\u6cd5\u8010\u53d7\u8be5\u836f\u7269\u3002.<\/p>\n<p><strong>\u8d5e\u52a9\u5546\uff1a<\/strong> \u57fa\u56e0\u6cf0\u514b\u548c\u7eaa\u5ff5\u65af\u9686-\u51ef\u7279\u7433\u764c\u75c7\u4e2d\u5fc3<\/p>\n<p><strong>\u8bd5\u7528\u7248\u8054\u7cfb\u65b9\u5f0f\uff1a<\/strong> Eli L. Diamond \u533b\u5b66\u535a\u58eb (212) 610-0243 \u6216 diamone1@mskcc.org<\/p>\n<p><strong>\u8981\u6c42\u60a3\u8005\u53c2\u4e0e\uff1a<\/strong> \u4efb\u4f55\u60a3\u6709ECD\u4e14BRAF\u9634\u6027\uff0c\u6216BRAF\u9633\u6027\u4f46\u65e0\u6cd5\u83b7\u5f97\u6216\u65e0\u6cd5\u8010\u53d7BRAF\u6291\u5236\u5242\u7684\u60a3\u8005\u3002\u60a3\u6709\u67d0\u4e9b\u773c\u90e8\u6216\u5fc3\u810f\u95ee\u9898\u7684\u60a3\u8005\u53ef\u80fd\u4e0d\u7b26\u5408\u5165\u7ec4\u6761\u4ef6\uff0c\u9700\u8981\u8fdb\u884c\u7b5b\u67e5\uff08\u4f46\u901a\u5e38\u53ef\u5728\u5c45\u4f4f\u5730\u9644\u8fd1\u5b8c\u6210\uff09\u3002 \u8be5\u7814\u7a76\u8981\u6c42\u6bcf\u6708\u524d\u5f80MSKCC\u5c31\u8bca\uff0c\u4f46\u5728\u53c2\u4e0e\u8bd5\u9a8c\u4e00\u5e74\u540e\uff0c\u53ef\u6539\u4e3a\u6bcf\u4e24\u4e2a\u6708\u4e00\u6b21\u3002.<\/p>\n<p><strong>\u5df2\u77e5\u53c2\u4e0e\u8be5\u8bd5\u9a8c\u5e76\u63a5\u6536ECD\u60a3\u8005\u7684\u4e2d\u5fc3\uff1a<\/strong> \u65af\u9686-\u51ef\u7279\u7433\u7eaa\u5ff5\u764c\u75c7\u4e2d\u5fc3\uff0c\u7f8e\u56fd\u7ebd\u7ea6\u5dde\u7ebd\u7ea6\u5e02<\/p>\n<p><strong>ClinicalTrials.gov \u6807\u8bc6\u7b26\uff1a<\/strong> NCT02649972<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective: This is a clinical trial of a new medication to treat patients with Erdheim-Chester disease whose ECD tissue (1) does NOT have the BRAF mutation or (2) whose [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[32],"class_list":["post-4418","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-drug-trial"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials\/4418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/media?parent=4418"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/zh\/wp-json\/wp\/v2\/study_trials_cat?post=4418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}